Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-01 @ 9:35 AM
Study NCT ID:
NCT00117156
Status:
COMPLETED
Last Update Posted:
2016-08-01
First Post:
2005-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-30
First Submit QC Date:
None
Study First Post Date:
2005-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-26
Results First Submit QC Date:
None
Results First Post Date:
2014-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-28
Last Update Post Date:
2016-08-01
Last Update Post Date Type:
ESTIMATED